Effect of Telmisartan on Paroxysmal Atrial Fibrillation Recurrence in Hypertensive Patients With Normal or Increased Left Atrial Size

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial

(2011) Andreas Goette et al.   Circulation-Arrhythmia and Electrophysiology

Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation

(2011) Roberto Fogari et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion

(2010) P. Marchese et al.   European Journal of Echocardiography

Left Atrial Volume Combined With Atrial Pump Function Identifies Hypertensive Patients With a History of Paroxysmal Atrial Fibrillation

(2010) Norihisa Toh et al.   HYPERTENSION

Focus on renin–angiotensin system modulation and atrial fibrillation control after GISSI AF results

(2010) Ornella Durin et al.   Journal of Cardiovascular Medicine

Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation

(2010) Peter M Okin et al.   JOURNAL OF HYPERTENSION

Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition

(2010) Markus P. Schneider et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients

(2009) R. Fogari et al.   HORMONE AND METABOLIC RESEARCH

Valsartan for Prevention of Recurrent Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Valsartan and Ramipril on Atrial Fibrillation Recurrence and P-wave dispersion in Hypertensive Patients With Recurrent Symptomatic Lone Atrial Fibrillation

(2008) R. Fogari et al.   AMERICAN JOURNAL OF HYPERTENSION

Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1receptor blockade in human atrial myocardium

(2008) Dirk von Lewinski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Possible Molecular Mechanisms by which Angiotensin II Type 1 Receptor Blockers (ARBs) Prevent the Development of Atrial Fibrillation in Insulin Resistant Patients

(2008) S.-I. Yamagishi et al.   HORMONE AND METABOLIC RESEARCH

Structural and Functional Remodeling of the Left Atrium

(2008) Grace Casaclang-Verzosa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation

(2008) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Volume Is a Predictor of Atrial Fibrillation Recurrence After Catheter Ablation

(2008) Sung-Hee Shin et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY